CHICAGO – September 19, 2023 – EVERSANA, a leading provider of commercialization services to the global life sciences industry, today announced that Sy Pretorius, Chief Operating Officer and President, Outsourced Solutions, has been named to the PharmaVoice 100 list for 2023.
Pretorius, who joined EVERSANA in November 2022, is a highly regarded leader in clinical development and commercial operations with more than 25 years of life sciences experience including multiple executive and advisory roles. 2023 marks the second time Pretorius has made the annual list of leaders in the life sciences industry, having also been named in 2017.
“Since joining our team less than a year ago, Sy has been instrumental in helping drive continued operational excellence across our organization,” said Jim Lang, CEO, EVERSANA. “We’re lucky to have him and could not be more thrilled to see him recognized by PharmaVoice as a Top 100 leader in the industry.”
The PharmaVoice 100 list salutes the trailblazers in the life sciences at the forefront of industry trends. They are standout leaders who go above and beyond the call of duty to push the industry forward while making a deep and lasting impact on their companies, colleagues, communities, or scientific pursuits.
Lang himself was recognized by the publication as a Red Jacket recipient in 2022, following two consecutive years of being named to the PharmaVoice 100. A complete list of winners for 2023 can be found here.
EVERSANA® is a leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.
Director, Corporate Communications
Tel: +1 414-434-4830
E-mail: [email protected]